Pharmacological modulation of carcinoembryonic antigen in human cancer cells: Studies with staurosporine

International Immunopharmacology

Volumn 2, Issue 5, 2002, Pages 641-651

  Prete, Salvatore P ^a   Cappelletti, Daniela ^a   Baier, Susanne ^a   Nasuti, Paola ^a   Guadagni, Fiorella ^b   Vecchis, Liana De ^a   Greiner, Jack W ^c   Bonmassar, Enzo ^a,d   Graziani, Grazia ^a   Aquino, Angelo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

^d CNR   (Italy)

Author keywords

Antigen modulation; Cancer; CEA; Immunotherapy; Molecular diagnosis; Staurosporine

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; PROTEIN KINASE INHIBITOR; STAUROSPORINE;

ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL MEMBRANE; CELL STRAIN MCF 7; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; CYTOSTASIS; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; PRIORITY JOURNAL; REGULATORY MECHANISM;

CARCINOEMBRYONIC ANTIGEN; CELL MEMBRANE; CYTOSOL; GENE EXPRESSION REGULATION; HUMANS; STAUROSPORINE; TUMOR CELLS, CULTURED;

EID: 18344392256     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(01)00192-8     Document Type: Article

References (49)

1. Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo
2. 131I-CC49) when given in combination with γ-interferon
3. In vitro and in vivo regulation of human tumor antigen expression by human recombinant interferons: A review
4. Immune response to a carcinoembryonic antigen polynucleotide vaccine
5. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine
6. Carcinoembryonic antigen as a target for cancer vaccines
7. Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge
8. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen
9. Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice
10. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction
11. Molecular detection of circulating solid carcinoma cells in the pheripheral blood: The concept of early systemic disease
12. Limitation of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood
13. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: Longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers
14. Modulation of tumor associated antigen expression and shedding by recombinant human leukocyte and fibroblast interferons
15. Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: Role for endogenous IFN-beta
16. The effects of γ-interferon combined with 5-Fluorouracil or 5-Fluoro-2′-deoxyuridine on proliferation and antigen expression in a panel of human colorectal cancer cell lines
17. Differential effects of recombinant Interferon-α and 5-Fluorouracil against colon cancer cells or against peripheral blood mononuclear cells
18. Drug-induced changes of carcinoembryonic antigen expression in human cancer cell: Effect of 5-Fluorouracil
19. Effect of the combined treatment with 5-fluorouracil, γ-interferon or folinic acid on carcinoembryonic antigen expression in colon cancer cells
20. Effect of 5-fluorouracil on carcinoembryonic antigen expression and shedding at clonal level in colon cancer cells
21. Drug-Induced modulation of carcinoembrionic antigen (CEA) expression in neoplastic cells from a patient with rectal cancer
22. Modulation of differentiation-related responses in human colon carcinoma cells by protein kinase inhibitor H-7
23. ++ dependent protein kinase
24. Inhibition of phorbol ester-caused induction of ornithine decarboxylase and tumor promotion in mouse skin by staurosporine, a potent inhibitor of protein kinase C
25. Staurosporine increases carcinoembryonic antigen expression in a human colon cancer cell line
26. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation
27. Cell spreading in Colo 201 by staurosporin is alpha 3 beta 1 integrin-mediated with tyrosine phosphorylation of src and tensin
28. Homotypic adhesion through carcinoembryonic antigen plays a role in hepatic metastasis development
29. Modulation of carcinoembryonic antigen release by glucosylceramide-implications for HT29 cell differentiation
30. Definition of monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues
31. New human cell lines
32. Characterization of WiDr: A human colon carcinoma cell line
33. Initiation and characterization of cultures of human colonic carcinoma with different biological characteristics utilizing feeder layers of confluent fibroblasts
34. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
35. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
36. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
37. Cloning of the complete gene for carcinoembryonic antigen: Analysis of its promoter indicates a region conveying cell type-specific expression
38. Staurosporine inhibits the proliferation, alters the cell cycle distribution and induces apoptosis in HT-29 human colon carcinoma cells
39. Cellular responses to interferon-gamma
40. Staurosporine, K-252 and UCN-01: Potent but nonspecific inhibitors of protein kinases
41. Preferential inhibition of the platelet-derived growth factor receptor tyrosine kinase by staurosporine
42. Contrasting actions of staurosporine, a protein kinase C inhibitor, on human neutrophils and primary mouse epidermal cells
43. Staurosporine induces protein kinase C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro
44. Cellular relocalisation of protein kinase C-theta caused by staurosporine and some of its analogues
45. Selective redistribution of protein kinase C isozymes by thapsigargin and staurosporine
46. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters
47. Biliary glycoprotein is overexpressed in human colon cancer cells with high metastatic potential
48. Phosphorylation regulates the delivery of MHC class II invariant chain complexes to antigen processing compartments
49. Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses